Упрощенная HTML-версия
310.
Jequier E. Leptin signaling, adiposity, and energy balance / E. Jequier // Ann N
Y Acad Sci. – 2002. – Vol. 967. – P. 379-388.
311.
Julius S. Autonomic nervous dysfunction in essential hypertension / S. Julius
// Diabetes Care. – 1991. – Vol. 14. – P. 249-259.
312.
Julius S. Changing role of the autonomic nervous system in human
hypertension / S. Julius // J. Hypertens. – 1990. – Vol. 8. – P. 59-65.
313.
Kannel W. B. Office assessment of coronary candidates and risk factor insights
from the Framingham study / W. B. Kannel // J Hypertension. – 1991. – Suppl.
9. – Р. 13-19.
314.
Keskin A. Fibrinolytic activity and platelet release reaction in essential
hypertension / A. Keskin, M. Tombuloglu, F. Buyukkececi // Jpn. Heart J. –
1994. – Vol. 35, № 6. – P. 757-763.
315.
Kim E. R. Impared anorectic effect of leptin in neurotensin receptor 1 –
deficient mice / E. R. Kim, A. Leckstrom, T. M. Mizuno // Behav. Brain. Res.
– 2008. – Vol.194, № 1. – P. 66-71.
316.
Kirmayer U. Patients who somatize in primary care: a longitudinal study of
cognitive and social characteristics / U. Kirmayer, J. M. Robbins // Psychol.
Med. – 1996; – V. 26. – P. 937-951.
317.
Koh K. K. Targeting converging therapeutic pathways to overcome
hypertension / K. K. Koh, M. J. Quon // Int. J. Cardiol. – 2009. – Vol. 132, №
3. – P. 297 – 299.
318.
Konstantinides S. Leptin-dependent platelet aggregation and arterial
thrombosis suggests a mechanism for atherothrombotic disease in obesity / S.
Konstantinides [et al.] // J. Clin. Invest. – 2001. – Vol. 108, № 10. – P. 1533 –
1540.
319.
Kopelman P. G. Obesity as a medical problem / P. G. Kopelman // Nature. –
2000. – Vol. 404. – P. 635–643.
320.
Lamon B. D. Inflammation at the Molecular Interface of Atherogenesis / B. D.
Lamon, D. P. Hajjar // Am. J. Pathol. – 2008. – Vol. 173, № 5. – 1253 – 1264.